Terms: = Prostate cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Treatment
15 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Genomic characterization of idh-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
3. 68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Verma P; Singh BK; Sudhan MD; Singh RK; Bagul SD; Chandak AR; Soni BK; Shelly D; Basu S
Clin Nucl Med; 2023 Dec; 48(12):e559-e563. PubMed ID: 37883060
[TBL] [Abstract] [Full Text] [Related]
4. Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
Duffau H
J Neurooncol; 2023 Mar; 162(1):237-244. PubMed ID: 36913047
[TBL] [Abstract] [Full Text] [Related]
5. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
Elife; 2023 Mar; 12():. PubMed ID: 36883553
[TBL] [Abstract] [Full Text] [Related]
6. BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme.
Xavier MA; Rezende F; Titze-de-Almeida R; Cornelissen B
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439854
[TBL] [Abstract] [Full Text] [Related]
7. Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing.
Shah K; Gagliano T; Garland L; O'Hanlon T; Bortolotti D; Gentili V; Rizzo R; Giamas G; Dean M
Oncogene; 2020 Sep; 39(39):6172-6189. PubMed ID: 32820253
[TBL] [Abstract] [Full Text] [Related]
8. Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in prostate cancer.
Gonthier K; Poluri RTK; Weidmann C; Tadros M; Audet-Walsh É
Mol Cancer Res; 2019 Aug; 17(8):1699-1709. PubMed ID: 31068457
[TBL] [Abstract] [Full Text] [Related]
9. cancer metabolism in a snapshot: MRS(I).
Julià-Sapé M; Candiota AP; Arús C
NMR Biomed; 2019 Oct; 32(10):e4054. PubMed ID: 30633389
[TBL] [Abstract] [Full Text] [Related]
10. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Subtypes of prostate cancer.
Arora K; Barbieri CE
Curr Oncol Rep; 2018 Jun; 20(8):58. PubMed ID: 29858674
[TBL] [Abstract] [Full Text] [Related]
12. Six-Transmembrane Epithelial Antigen of prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.
Han M; Xu R; Wang S; Yang N; Ni S; Zhang Q; Xu Y; Zhang X; Zhang C; Wei Y; Ji J; Huang B; Zhang D; Chen A; Li W; Bjerkvig R; Li X; Wang J
Neoplasia; 2018 Jun; 20(6):543-554. PubMed ID: 29730475
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemically detected idh1
Hinsch A; Brolund M; Hube-Magg C; Kluth M; Simon R; Möller-Koop C; Sauter G; Steurer S; Luebke A; Angerer A; Wittmer C; Neubauer E; Göbel C; Büscheck F; Minner S; Wilczak W; Schlomm T; Jacobsen F; Clauditz TS; Krech T; Tsourlakis MC; Schroeder C
World J Urol; 2018 Jun; 36(6):877-882. PubMed ID: 29427004
[TBL] [Abstract] [Full Text] [Related]
14. cancer/Testis Antigens: "Smart" Biomarkers for Diagnosis and Prognosis of prostate and Other cancers.
Kulkarni P; Uversky VN
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362316
[TBL] [Abstract] [Full Text] [Related]
15. The CpG island methylator phenotype: what's in a name?
Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
[TBL] [Abstract] [Full Text] [Related]
